Tredje Ap Fonden Abb Vie Inc. Transaction History

Tredje Ap Fonden

$10.8 Billion
Q3 2024

A detailed history of Tredje Ap Fonden transactions in Abb Vie Inc. stock. As of the latest transaction made, Tredje Ap Fonden holds 733,120 shares of ABBV stock, worth $129 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

733,120

Previous 714,230 2.64%

Holding current value

$129 Million

Previous $123 Million 18.18%

% of portfolio

1.35%

Previous 1.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$163.84 - $199.33 $3.09 Million - $3.77 Million	18,890 Added 2.64%	733,120 $145 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $26.4 Million - $30.8 Million	170,500 Added 31.36%	714,230 $123 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $7.4 Million - $8.43 Million	46,300 Added 9.31%	543,730 $99 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $5.15 Million - $5.8 Million	-37,440 Reduced 7.0%	497,430 $77.1 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $95,917 - $111,038	-718 Reduced 0.13%	534,870 $79.7 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $4.02 Million - $5.01 Million	30,364 Added 6.01%	535,588 $72.2 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $4 Million - $4.61 Million	27,654 Added 5.79%	505,224 $80.5 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $5.26 Million - $6.31 Million	-38,018 Reduced 7.37%	477,570 $77.2 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $31 Million - $35.6 Million	231,097 Added 81.23%	515,588 $69.2 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $17.6 Million - $22.4 Million	-128,000 Reduced 31.03%	284,491 $43.6 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $263,960 - $327,500	-2,000 Reduced 0.48%	412,491 $66.9 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $8.25 Million - $10.4 Million	-76,828 Reduced 15.64%	414,491 $56.1 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $36.2 Million - $41.1 Million	-340,000 Reduced 40.9%	491,319 $53 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $10.3 Million - $11.5 Million	98,000 Added 13.36%	831,319 $93.6 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $17.2 Million - $18.9 Million	168,000 Added 29.72%	733,319 $79.4 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $402,450 - $543,350	-5,000 Reduced 0.88%	565,319 $60.6 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $2.58 Million - $3.02 Million	30,000 Added 5.55%	570,319 $50 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $23.6 Million - $31.5 Million	321,183 Added 146.57%	540,319 $53 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $2.39 Million - $3.62 Million	37,027 Added 20.33%	219,136 $16 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $1.54 Million - $1.93 Million	-21,342 Reduced 10.49%	182,109 $16.1 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $1.04 Million - $1.25 Million	-16,451 Reduced 7.48%	203,451 $15.4 Million
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $1.31 Million - $1.67 Million	19,907 Added 9.95%	219,902 $16 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $1.58 Million - $1.86 Million	20,496 Added 11.42%	199,995 $16.1 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $6.06 Million - $7.47 Million	-77,827 Reduced 30.24%	179,499 $16.5 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $88,910 - $98,840	-1,000 Reduced 0.39%	257,326 $24.3 Million
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $4.56 Million - $5.4 Million	-50,809 Reduced 16.44%	258,326 $23.9 Million
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $800,487 - $1.07 Million	8,700 Added 2.9%	309,135 $29.3 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $104,785 - $114,905	1,170 Added 0.39%	300,435 $29.1 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $20.9 Million - $26.7 Million	299,265	299,265 $26.6 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account